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Context. A major barrier to widening and sustaining palliative care service
provision is the requirement for better selection and use of outcome measures.
Service commissioning is increasingly based on patient, carer, and service
outcomes as opposed to service activity.
Objectives. To generate recommendations and consensus for research in
palliative and end-of-life care on the properties of the best outcome measures,
enhancing the validity of proxy-reported data and optimal data collection time
points.
Methods. An international expert ‘‘workshop’’ was convened and an online
consensus survey was undertaken using the MORECare Transparent Expert
Consultation to generate recommendations and level of agreement. We focused
on three areas: 1) measurement properties, 2) use of proxies, and 3)
measurement timing. Data analysis comprised descriptive analysis of aggregate
scores and collation of narrative comments.
Results. There were 31 workshop attendees; 29 recommendations were
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926 Vol. 46 No. 6 December 2013Evans et al.recommendations by area were the following: 1) the properties of the best
outcome measures are responsive to change over time and capture clinically
important data, 2) to enhance the validity of proxy data requires clear and specific
guidelines to aid lay individuals’ and/or professionals’ completion of proxy
measures, and 3) data collection time points need clear identification to establish
a baseline.
Conclusion. Outcome measurement in palliative and end-of-life care requires
the use of psychometrically robust measures that are clinically responsive, with
defined data collection time points to establish a baseline and clear
administration guidelines to complete proxy measures. To further the field
requires clinical imperatives to more closely inform recommendations on
outcome measurement. J Pain Symptom Manage 2013;46:925e937.  2013 U.S.
Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.Key Words
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Widening access to palliative and end-of-life
(EOL) care services is advocated with corrobo-
ration of patient1 and carer benefits,2 greater
potential for health service cost savings,3,4 and
increasing demand with an aging population.5
A major barrier is the requirement for better
selection and use of outcome measures to
demonstrate the effectiveness of services. Com-
missioners of health and social care services
increasingly require service providers to use
patient, carer, and service outcomes to demon-
strate a service’s safety, effectiveness, and qual-
ity as opposed to detailing service activity.6,7 In
research and clinical practice, a multitude of
measures are used, and frequently these mea-
sures are not validated with palliative care pop-
ulations.8 This hampers meta-analyses, limits
responsiveness to change in outcome, evaluat-
ing service effectiveness, and developing the
evidence base to inform best practice.9
Trials and nonrandomized designs in pallia-
tive and EOL care are often compromised by
the use of untested outcome measures,10,11
measures not developed for palliative care pop-
ulations,12 uncertainty as to the best measure-
ment time points,13 and the use of measures
for symptom change with less use of measures
encompassing the multiple domains of pallia-
tive care (e.g., Palliative care Outcome Scale
[POS], Edmonton Symptom Assessment Sys-
tem).12 These limitations are not unique to pal-
liative and EOL care. The COnsensus-based
Standards for the selection of healthMeasurement INstruments is a comprehensive
checklist for assessing the quality of the mea-
surement properties of health status question-
naires. The checklist was developed in
response to the rapid increase in health status
questionnaires and the need for quality criteria
to compare measures in systematic reviews,
identify shortcomings, and design studies vali-
dating measures.14,15
Palliative and EOL care involves people with
increasing debility associated with advancing
disease and has a broad mandate of care provi-
sion, with intended outcomes of improving
quality of life for patients and their caregivers.16
The nature of palliative and EOL care requires
measurement properties that accommodate
the following: the multiple domains of pallia-
tive care; to change over time and increasing
levels of fatigue; the use of proxies, particularly
when individuals are near to death; and timing
to detect change and monitor sustainment of
change. These challenges are well reported,
and international advancements to address
them are evident: projects such as the Palliative
Care Outcomes Collaboration in Australia
that uses national standardized assessments of
palliative care outcomes17,18 and a European
collaboration, entitled PRISMA, focused on
promoting best practice in the measurement
of EOL care (Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses)11 working
with a European Association of Palliative Care
(EAPC) Taskforce on patient-reported out-
come measures (PROMs) in palliative care to
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selecting and usingmeasures.21 Internationally,
there is increasing use of multi-domain pallia-
tive care measurement tools in research and
clinical practice (e.g., POS and Support Team
Assessment Schedule [STAS]).22
No work, however, has considered specific
recommendations for the use and selection of
outcome measures in trials and nonrandom-
ized studies of palliative and EOL care interven-
tions. This article reports on an international
outcome measurement workshop and online
consensus survey that aimed to identify agreed
best practice on selecting and using outcome
measures. The work is part of the Methods Of
Researching End of life Care (MORECare) pro-
ject, developing evidence-based guidance on
the design and conduct of evaluative research
on palliative and EOL care. MORECare inte-
grated data from three systematic reviews23e25
and five workshops26,27 to generate a statement
(the MORECare statement) that sets clear stan-
dards on good research practice in evaluating
services and treatments in palliative and EOL
care.28 This paper reports on the outcomemea-
surement workshop.Methods
Setting
An invitation-only workshop was held as
a joint initiative between the MORECare andFig. 1. Flow diagram of tPRISMA projects at the 2011 EAPC conference
to further the European work undertaken by
PRISMA11 and the EAPC Taskforce on PROMs
in palliative care.19
Participants
Holding the workshop at an international
conference intended to enable participation by
international experts in palliative care research,
service provision, and policy. Participants were
identified from the EAPC online conference
program and considered experts from their
publications. Fifty-nine individuals were identi-
fied and received a personal e-mail invitation
to attend the workshop and a single reminder
e-mail.
Design
We used the MORECare Transparent Expert
Consultation method, which incorporates
consensus methods of nominal group and con-
sensus survey.29 The Transparent Expert Con-
sultation comprised a staged process: Stage
Ididentifying critical issues from the litera-
ture; Stage IIda workshop with experts on
the issues using nominal group technique to
generate recommendations; and Stage IIIdan
online consensus survey to prioritize and iden-
tify areas of contention/uncertainty (Fig. 1).
Stage I: Identifying Critical Issues. Critical issues
on selecting and using outcome measures inhe study design.
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systematic reviews of intervention studies12
and outcome measurement.30 The workshop
and consensus survey focused on three critical
questions:
1. What are the properties of the best pri-
mary outcome measures for evaluation
of palliative and EOL care services?
2. How can we best enhance the validity of
proxy-reported outcome data?
3. When are the optimal time points to col-
lect outcome data to evaluate the effec-
tiveness of service models in palliative
and EOL care?Stage II: Workshop. Participants received a pre-
workshop briefing pack detailing the aim, crit-
ical questions, and workshop format. The
workshop format comprised presentations on
the MORECare project and the project’s inter-
face with the PRISMA/EAPC Taskforce, fol-
lowed by three structured groups of seven
to 13 participants each focused on one of the
critical questions. The group structure used
a modified nominal group facilitated and
scribed by members of the MORECare and
PRISMA projects. The facilitators guided par-
ticipants through a structured process of: 1)
brief discussion, 2) individual writing of rec-
ommendations and ranking, and 3) individ-
uals in turn reading out their highest ranked
recommendations until individual lists were
exhausted (or time exceeded).31 The scribes
wrote the recommendations and ranking on
flip-charts, and each small group discussed
and agreed on the final priority order, which
they presented and discussed with the whole
group. Participants listed and ranked recom-
mendations from one to five (highest to low-
est) on structured A4 sheets detailing the
respective group question, the ranking scaleTable 1
Recommendation Agreement: Interpretati
Median Regions and IQR
7e9
4e6
1e3
IQR in one region
IQR in any three-point region
IQR ¼ interquartile range.and boxes to list recommendations, rank,
and detail rationale.
Stage III: Consensus Survey. Recommendations
were posted online to the workshop partici-
pants (excluding the facilitators and scribes)
and members of the MORECare Project Advi-
sory Group. Participants received a personal-
ized e-mail invitation and reminder after two
weeks. The online participants ranked, from
one to nine (strongly disagree to strongly
agree), the extent they agreed with a recom-
mendation and used free-text spaces to com-
ment on each recommendation.
Data Analysis
Individual recommendations and ranking
were entered into Excel spreadsheets with as-
signed participant identification numbers.
Flip-chart records and the scribes’ notes were
typed. Three researchers (C.J.E., H.B., M.G.)
drew on qualitative analysis to identify themes
in the recommendations and assign codes32
and collate typed data. Coded recommenda-
tions were rearranged by theme in Excel
spread sheets. Duplicates were combined and
recommendations arranged by priority rank-
ing. The recommendations retained partici-
pants’ original language, with amendments to
enhance clarity. A third researcher (I.J.H.) re-
viewed the analysis and proposed recommen-
dations. After combining for duplicates, we
included all recommendations in the online
survey that participants had ranked three and
above and/or participants’ listed recommen-
dations formed a prominent theme. The
MORECare research team reviewed and
agreed on the recommendations for the on-
line survey.
Analysis of scaled data followed conven-
tional rules of descriptive statistics (frequen-
cies and medians) and plots (box and
whisker plots of interquartile ranges toon of Median Regions and IQR34
Interpretation
Recommendations are indicated
Recommendations are equivocal
Recommendations not indicated
Strict agreement for recommendation
Broad agreement for recommendation
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[Table 1]).34 Narrative comments were col-
lated by recommendation, themes identified,
and rearranged in Excel sheets to enable com-
parison.35 The analysis of comments intended
to aid understanding and provide illustrative
examples of the issues raised by the proposed
recommendations.36
Ethics
The study was approved by the University of
Manchester Research Ethics Committee (refer-
ence number: 10328).Results
Participants
Thirty-one international and national ex-
perts attended the workshop comprising se-
nior academics, policy makers, and clinicians,
representing countries from Europe (e.g.,
Norway, Belgium, U.K., Italy, Germany), North
America, and Australia. All held a title of pro-
fessor or doctor. Twenty-eight experts com-
pleted the online survey.
Recommendations and Levels of Agreement
The workshop generated 155 individual rec-
ommendations; 29 recommendations were in-
cluded in the online consensus survey after
combining duplicates and completing analysis.
The recommendations included in the online
survey were either generic describing good
practice in choosing and administering out-
come measures in effectiveness research or fo-
cused on specific challenges in research on
palliative and EOL care (Table 2). Overall,
the median levels of agreement for the 29 rec-
ommendations showed that most recommen-
dations (n ¼ 26) were indicated with
medians $7; none were not indicated (me-
dians #3) (Table 2). However, the levels of
agreement across the three areas varied. The
recommendations on: 1) the properties of
outcome measures showed mainly strict agree-
ment that the recommendations were indi-
cated (n ¼ 6/11 [Fig. 2]), 2) enhancing
proxy data showed mainly broad agreement
(n ¼ 6/9 [Fig. 3]), and 3) data collection
time points all showed broad agreement
(n ¼ 9 [Fig. 4]). Recommendations in which
the level of agreement was equivocal or broadwere considered as uncertain or contentious.
Qualitative analysis of the workshop discus-
sions and the online survey free-text comments
informed understanding on these areas. We
present quotes to illustrate these debates.
Properties of the Best Outcome Measurements
Properties of the best primary outcome mea-
sures formed 11 recommendations (Fig. 2;
Table 2). Overall, there was strict agreement
that the properties of the best outcome mea-
sures required valid measures that were respon-
sive to change over time, captured clinically
relevant data, and were easy to administer
across care settings (Recommendations 1, 2, 5,
6, 9, 10). The text data indicated that measures
required flexibility in the administration of the
measure (e.g., PROMs, observation) to ensure
responsiveness to patients’ fluctuating capacity
and increasing fatigue, notably in the last days
and hours of life. An area of less certainty was
the recommendation that a measure was appro-
priate for clinical practice, research, and audit,
with broad agreement indicated but with the
widest spread (Recommendation 11) (Fig. 2).
Uncertainty centered on accommodating
competing priorities for practice, research, and
audit, summarized by a survey respondent as:
It is impossible to serve all 3 masters opti-
mally. They need to be optimized for one
or perhaps two goals. (ID OMs 6)
Measures in research required greater detail
than the comparatively brief measures re-
quired in clinical practice. However, there
was agreement on the importance of research
capturing clinically relevant data (Recommen-
dation 5) that could be integrated into clinical
care (Recommendation 10). A way forward dis-
cussed in the workshop and in the online sur-
vey comments was the use of ‘‘core outcomes’’
with additions depending on the context, as
a survey respondent stated:
. core outcomes (for all settings) and
others setting-specific, this will give a more
accurate approach, for the process and for
specific settings. (ID OMs 12)Enhancing the Validity of Proxy-Reported
Outcome Data
Greater uncertainty surrounded the seven
draft recommendations on enhancing the
Table 2
Recommendations on Selecting and Using Outcome Measures by Area and Level of Agreement
No.
Area 1: Properties of the Best Primary Outcome Measures in Evaluations of Palliative and EOL Care
Should . Median (IQR)
Strict agreement that recommendation is indicated
1 Be easy to administer and interpret (e.g., short and low level of complexity). 8 (7e9)
2 Be applicable across care settings to capture change in outcomes by location (e.g., patient’s home,
hospital, hospice).
8 (7e9)
5 Be responsive to change over time and capture clinically important data. 8 (7.5e8)
6 Have demonstrated content validity. 8 (7e9)
9 Have demonstrated reliability. 8 (7e9)
10 Be integrated into clinical care. 8 (7e9)
Broad agreement that recommendation is indicated
3 Work across a disease trajectory from diagnosis to death. 7 (6e8)
4 Be culturally sensitive to a respective population group (e.g., linguistically and culturally). 7.5 (6e8)
7 Have demonstrated construct validity. 8 (6e9)
8 Have demonstrated face validity. 8 (6e9)
11 Be appropriate for clinical practice, research, and audit uses. 7 (6e9)
No.
Area 2: Enhancing the Validity of Proxy Data in Evaluations of Palliative and EOL Care Services
Requires . Median (IQR)
Strict agreement that recommendation is indicated
14 Clear and specific guidelines to aid lay individuals’ and/or professionals’ completion of proxy
measures.
8.5 (7e9)
20 Capture of patients’ experiences of care (e.g., emotional effect, physical effect). 8 (7e9)
17 That data from patients and proxy measures should be differentiated in the dataset. 8 (7e9)
Broad agreement that recommendation is indicated
12 PROMs as the gold standard in evaluations of palliative and EOL care services; proxy measures
should be used only when the patient concerned is unable to provide the data.
7 (5e9)
15 Proxy measures to have demonstrated criterion validity. 7 (6e9)
16 Proxy measures to have demonstrated interrater validity.
19 Capture of the core intervention. 7 (6e9)
Broad agreement that recommendation is equivocal
13 That to increase reliability in evaluations of palliative and EOL care services, proxy measures should
only be used in conjunction with observer measures.
6 (5e7)
18 Factors that may influence proxy raters to be investigated and reported (e.g., degree of emotional
involvement or neutrality).
6.5 (4e7.3)
No. Area 3: Data Collection Time Points in Evaluations of Palliative and EOL Care Require . Median (IQR)
Broad agreement that recommendation is indicated
21 Clear identification of time points to establish a baseline. 7 (6e9)
22 Time points in evaluations on palliative and EOL care services need to be established before
conducting the evaluation.
7 (5e8)
23 That when prospective measurement is used, endpoints should correspond to when the effect of the
intervention is expected to take place.
7 (6e8)
24 That when prospective measurement is used, time points should correspond to a combination of
fixed and flexible time points (e.g., a flexible time point may be triggered when a threshold is
reached).
7 (6e8)
26 Process measures to understand the implementation of the intervention. 8 (6e9)
27 A measurement window for time points is defined to capture baseline data and the impact of the
intervention.
7 (5e7.3)
28 The choice of time points is influenced by the expected effect of the intervention, the study
setting(s) (e.g., patient’s home, hospital) and the disease trajectory and stage.
7 (5.8e8.3)
29 That the frequency of measurement is determined by the number, length, and degree of burden of
the data collection tools.
7 (6e8)
Broad agreement that recommendation is equivocal
25 In retrospective evaluations that death should form the endpoint. 6 (4e7)
EOL ¼ end of life; IQR ¼ interquartile range; PROMs ¼ patient-reported outcome measures.
930 Vol. 46 No. 6 December 2013Evans et al.validity of proxy-reported data, with wide vari-
ance in degrees of agreement (Fig. 3). There
was strict agreement that to enhance proxy
measures required clear specific guidelines to
aid completion, the differentiation of patient
and proxy data in datasets and that proxymeasures captured patients’ experiences of
care (Recommendations 14, 17, 20) (Table 2).
Two recommendations were equivocal and
concerned increasing the reliability of proxy
measures and understanding bias (Recommen-
dations 13 and 18). Recommendation 13 that
Fig. 2. Properties of the best primary outcome measures in evaluations of palliative and EOL care. Box and whis-
ker plot of the interquartile ranges and medians of level of agreement for the 11 recommendations (box: 25th
and 75th percentiles; whiskers: minimum and maximum).
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junction with observer measures was viewed as
useful in the absence of PROMs data. However,Fig. 3. Enhancing the validity of proxy data in evaluations of
interquartile ranges and medians of level of agreement for t
and 75th percentiles; whiskers: minimum and maximum).uncertainty surrounded the validity of using
such measures in conjunction and the best
method of statistical analysis. Best researchpalliative and EOL care. Box and whisker plot of the
he nine measurement recommendations (box: 25th
Fig. 4. Data collection time points in evaluations of palliative and EOL care. Box and whisker plot of the inter-
quartile ranges and medians of level of agreement for the nine recommendations (box: 25th and 75th percen-
tiles; whiskers: minimum and maximum).
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ther research was required on the contribution
of using measures in conjunction to enhance
reliability. There was agreement that Recom-
mendation 18 was indicated on the importance
of investigating factors that may influence
proxy raters to reduce bias. However, partici-
pants’ comments questioned the feasibility of
this in research practice because of the com-
plexity in collecting and interpreting such data.
The main area of contention was the recom-
mendation on the precedence of PROMs over
proxy measures, indicated by the wide spread
(Recommendation 12) (Fig. 3). The survey
participants’ comments indicated that using
PROMs data alone negated that palliative
care encompassed both patients and their fam-
ilies, would fail to capture data in the last days
of life from, for example, observation, and the
relevance of clinical data, for example, medica-
tion use. Survey participants advocated the re-
quirement for multiple measures in research
on palliative care. The workshop delegates ad-
vocated that proxy measures were ‘‘second
choice’’ over PROMs, but proxy data were ‘‘in-
dispensable’’ in palliative care because of pa-
tients’ deteriorating capacity and increasing
fatigue.Optimal Data Collection Time Points in
Clinical Trials and Evaluations of
Interventions
There was broad agreement that the eight
recommendations on time points were indi-
cated (Fig. 4). The wide distribution and no
strict agreement on the recommendations sug-
gested uncertainty/contention. The recom-
mendation of death as the endpoint in
retrospective data analysis was equivocal (Rec-
ommendation 25). The online survey com-
ments revealed that death as an endpoint was
considered too narrow as it failed to capture
the holistic nature of palliative care, which en-
compasses carers and family members across
the disease trajectory and into bereavement.
However, death could form an important end-
point in retrospective data analysis depending
on the objectives of the study, as one workshop
participant stated:
Use death as [an] endpoint and count bur-
den from this e as time or referral/first as-
sessment may vary so greatly. (ID G2.015)
Although the workshop participants used
the term endpoint, this caused confusion in
the online survey, and alternative terms of an-
chor point or starting point were proposed.
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of scores and finding of an equivocal
recommendation.Discussion
Research on palliative and EOL care is beset
by well-reported challenges rooted in involving
individuals with advanced illness in research
and their families, the multiple domains of
palliative care provided across health and so-
cial care, and the intention to improve quality
of life in the face of deterioration.9,10,12,37
These challenges have hampered the use and
selection of outcome measures in trials and
nonrandomized studies on palliative and
EOL care services.38,39 We critically discuss
three main areas to further this field of re-
search: priority measurement properties, in-
corporating proxy data, and identifying time
points.
Measurement Properties
The findings corroborate work undertaken
by the PRISMA project that research on pallia-
tive care requires the use of short, brief out-
come measures that accommodate patients’
increasing levels of fatigue and minimize bur-
den.8,20,40 This does not equate to ‘‘easy’’ to
measure aspects of care, but areas important
to patients and families that encompass de-
sired benefit from a service or intervention.41
The challenge is to use measures that capture
the multiple domains of palliative care, but in
a format that is short and easy to interpret.
Our findings support the requirement for
measures used in palliative care to be applica-
ble for both clinical practice and research.11,41
Work in Australia has demonstrated the feasi-
bility of collecting national palliative care out-
come data across specialist services using
defined measurement tools incorporated in
routine practice and the potential for national
benchmarking for care quality and out-
comes.17 However, our findings and the
PRISMA work show that there are competing
priorities between the requirements of a mea-
sure used in clinical practice and research.40
Time pressure in clinical practice necessitates
the use of short measures (e.g., six to 10
items)8 that are easy to administer and inter-
pret to inform clinical decisions. In researchevaluating the effectiveness of an intervention
or service, the measure(s) used needs to dem-
onstrate the degree of change over time, not
simply the presence or absence of, for exam-
ple, a symptom. Both clinical and research set-
tings, however, require the use of measures
with validated psychometric properties to
ensure scientific rigor and enhance clinical
decision making.40 To accommodate these
competing priorities (and similarities) of our
findings, the PRISMA work suggests the use
of core measures for clinical and research
practice and further assessment of specific
areas for research when indicated.8 Mularski
et al.42 propose, from consensus work, that
evaluation studies use an outcomes measure-
ment strategy that encompasses three outcome
categories: condition specific, patient out-
comes, and family/caregiver outcomes. Mea-
sures such as POS (http://pos-pal.org),43 the
Edmonton Symptom Assessment System,44
and Memorial Symptom Assessment Scale45
are examples of measures commonly used in
both palliative care clinical practice and re-
search,41 are validated with palliative care pop-
ulations, and are short to administer and
multidimensional.
Palliative care is provided internationally
across health and social care settings and to pa-
tients with cancer and increasingly to those
with nonmalignant illness. Our data indicate
the requirement for measures to be culturally
sensitive and be applicable across care settings
to capture change in outcomes, particularly for
patients who move between care settings, for
example, at home, inpatient hospital, or care
home. The development of existing measures
is apparent, notably POS, with work to increase
cultural sensitivity for countries both in Afri-
ca46 and Europe,47 and use with disease groups
other than cancer.22 Further validation work of
palliative care measures like POS, however, is
required for specific patient groups, notably
patients with dementia48,49 and for social
care settings (e.g., care homes).50
Incorporating Proxy Data
Our data showed the clinical complexity for
palliative care in using PROMs as the ‘‘gold
standard’’ in research. The complexity of palli-
ative care service provision to meet diverse
care needs of patients and families necessitates
data collection from multiple sources. It is
934 Vol. 46 No. 6 December 2013Evans et al.an essential requirement in research on pallia-
tive and EOL care to expect and plan for
missing data because of deterioration.27,42
Proxy-reported outcome data are integral sour-
ces in palliative care, particularly at points of
a patient’s deterioration or unstable symptoms
when physical and/or mental debility may
prevent use of a PROM. At these points, pa-
tients likely experience increasing symptom
distress, points at which it is imperative to un-
derstand the effectiveness of the care and
treatment provided. PROMs, such as POS
and Memorial Symptom Assessment Scale,
are validated for use with a proxy.43,49,51
However, the extent a proxy report reflects
a patient response depends on the degree of
agreement and the direction of agreement
(e.g., proxies report high ratings when pa-
tients report low) between the proxy and pa-
tient; the greater the level of agreement, the
greater the confidence in including proxy re-
ports.51 Studies in palliative care have shown
wide variance in agreement responses depend-
ing in particular on the variable measured and
the patient-proxy dyad.51e53 Studies, for exam-
ple, report high agreement for observable pa-
tient variables (e.g., ability to transfer) and
moderate to low for psychological domains
and subjective patient experiences (e.g., qual-
ity of life).53,54 In patient and caregiver dyads,
higher agreement is reported than in patients
and health care provider dyads,51 but over
time, similar reporting is seen as practitioners’
knowledge of their patients increases.53 Our
findings correlate with studies on proxy and
patient reporting that to further the inclusion
of proxy reports requires greater understand-
ing of the factors that influence reporting to
improve reliability (e.g., degree of neutrality,
knowledge of patient), further development
of proxy measures to capture patients’ subjec-
tive experiences (e.g., quality of life), and
ways to enhance statistical analysis.51e54
Identifying Time Points
Identifying optimal time points intends to
maximize the number of patients available at
consecutive points of measurement to demon-
strate the effectiveness of the intervention.13
Our data show that best practice to identify
time points was the area of most uncertainty,
with broad or equivocal agreement surround-
ing the recommendations posed. Identifyingtime points in research on palliative and
EOL care is a prominent methodological chal-
lenge rooted in minimizing patient burden,
imprecision in identifying the state of ‘‘dying,’’
and attrition.13,34 In particular, attrition from
increasing debility minimizes data collection
for individuals with the greatest symptom bur-
den and compromises a study’s internal valid-
ity with overrepresentation of the ‘‘healthiest’’
patients.55 Hence, careful planning of time
points is crucial.
Our data show broad agreement for the rec-
ommendations on establishing time points be-
fore the evaluation, and the frequency of
measurement is determined by the degree of
burden of the data collection tools. These rec-
ommendations are likely too narrow, hence
the wide spread of responses. The timing and
frequency of measurements is embedded
within a conceptual framework for the inter-
vention. The conceptual framework is devel-
oped from the research question and detailed
understanding of the intended intervention
outcome/benefit, the expected response pat-
tern (e.g., two weeks post-consultation with
the palliative care clinician), and the phase of
illness (e.g., stable disease, deteriorating, dying
phase).18,56,57
The recommendation of death as an end-
point in retrospective evaluations was equivo-
cal. This likely reflects misunderstanding of
the term ‘‘endpoint.’’ The use of anchor point
from which data are included may have in-
creased clarity. Retrospective evaluations in
palliative care are important study designs.
Prospective designs are hampered by impreci-
sion in the identification of the state of dying,
particularly in measures of quality of life,
which often deteriorate in the last days of
life.13 A way to accommodate this is prospec-
tive observations and data analysis that uses
both prospective analysis from the baseline
and retrospective analysis from the last obser-
vation before death.58 Death is a fixed anchor
point for the whole sample and provides more
reliable data on the clinical outcomes over
time.59
Limitations
We undertook the consensus workshop at an
international conference in palliative care.
This enabled participation by international ex-
perts but limited invitations to those attending
Vol. 46 No. 6 December 2013 935Outcome Measurement in Palliative Care Researchthe conference and the time available, particu-
larly for discussion. The use of clear questions
and a structured process to generate the rec-
ommendations was intended to maximize the
time. We limited the online consensus to a sin-
gle round to enhance the response rate. This
prevented wider consultation on the survey
comments that detailed reasons for scoring
as well as measures of central tendency and dis-
persion. There is no agreement on the best
method for mathematical aggregation in con-
sensus surveys.29 We used an implicit approach
of medians and measure of dispersion29 and
the Jones and Hunter established method for
interpreting scaled data.30Conclusions
To enable the wide application and interpre-
tation of outcome measures in palliative and
EOL care, the measurement properties need
to be validated for this population, capture
multidimensional components, and be broadly
applicable across health systems, populations,
disease trajectories (including post-death for
bereaved carers), languages, and cultures.
The best measures have essential properties
of simplicity of use and good interpretability,
the ability to measure clinically important
change, and reporting by a patient or proxy in-
formant. To further the field requires clinical
imperatives to more closely inform recommen-
dations on outcome measurement.Disclosures and Acknowledgments
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